US EditionDiagnosed prevalent cases of multiple sclerosis to increase by 0.19 per cent AGR in 7MM during 2024-34, forecasts GlobalData - Express Pharma
Summary by Express Pharma
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Diagnosed prevalent cases of multiple sclerosis to increase by 0.19 per cent AGR in 7MM during 2024-34, forecasts GlobalData - Express Pharma
The diagnosed prevalent cases of multiple sclerosis (MS) in the seven major markets (7MM*) are projected to increase from 1.61 million in 2024 to 1.64 million in 2034 at an annual growth rate (AGR) of negative 0.19 per cent, forecasts GlobalData. GlobalData’s latest report, “Multiple Sclerosis Epidemiology Analysis and Forecast to 2034,” reveals that in 2034, the US is forecasted to experience the greatest number of diagnosed prevalent cases of …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
